Co‐administration of difluoromethylornithine (DFMO), a specific inhibitor for ODC1[35] also significantly blocked paclitaxel‐induced enrichment of ALDH+ cells in breast cancer cells (Figure S2M, Supporting Information). Here, ODC1 is linked to breast cancer.